中文版安德森脑肿瘤症状评估量表的信效度检验

doi:10.3761/j.issn.0254-1769.2021.06.009

摘要/Abstract

摘要：

目的检验中文版安德森脑肿瘤症状评估量表（M.D. Anderson Symptom Inventory Brain Tumor Module,MDASI-BT）的信效度。方法 2019年12月—2020年10月,采用便利抽样法对云南省某三级甲等医院208例原发性脑肿瘤患者进行问卷调查,检验量表的信效度。结果中文版MDASI-BT共28个条目,包括22个症状评估条目和6个症状干扰评估条目。探索性因子分析结果显示,22个症状评估条目提取6个公因子,累计方差贡献率为63.137%; 6个症状干扰条目提取1个公因子,累计方差贡献率为63.368%。总量表的Cronbach’s α系数为0.920,折半系数为0.894。结论中文版MDASI-BT具有较好的信效度,可用于脑肿瘤患者症状严重程度及对生活干扰的评估。

关键词: 脑肿瘤, 症状, 评估工具, 信度, 效度, 肿瘤护理

Abstract:

Objective To evaluate the reliability and validity of the Chinese version of M.D. Anderson Symptom Inventory Brain Tumor Module（MDASI-BT） as a tool for assessing multiple symptoms in Chinese brain tumor patients. Methods From December 2019 to October 2020,208 patients with primary brain tumor were recruited by convenience sampling method from a tertiary hospital in Yunnan Province for a questionnaire survey,in order to evaluate the reliability and validity of the instrument. Results The Chinese version of MDASI-BT contained 28 items,including 22 symptom assessment items and 6 symptom interference assessment items. Through exploratory factor analysis,6 common factors extracted from 22 symptom assessment items could account for 63.137% of the cumulative variance. One common factor extracted from 6 symptom interference assessment items could explain a cumulative variance of 63.368%. The Cronbach’s α coefficient of the instrument was 0.920,and the split-half reliability was 0.894. Conclusion The Chinese version of MDASI-BT showed high reliability and validity. It can be used as a specific and practical tool for assessing cancer-related symptoms and its disturbance of life in patients with brain tumor.

Key words: Brain Tumor, Symptom, Assessment Tools, Reliability, Validity, Oncologic Nursing Care

蒲树英,姚芡芡,蒋玮,罗艳芳. 中文版安德森脑肿瘤症状评估量表的信效度检验[J]. 中华护理杂志, 2021, 56(6): 855-860.

PU Shuying,YAO Qianqian,JIANG Wei,LUO Yanfang. Reliability and validation study of the Chinese version of M.D. Anderson Symptom Inventory Brain Tumor Module[J]. Chinese Journal of Nursing, 2021, 56(6): 855-860.

图/表 3

表1 中文版安德森脑肿瘤症状评估量表症状评估条目因子载荷矩阵

Table 1 Rotated factor loadings of the symptom assessment items of the Chinese version of MDASI-BT

表2 中文版安德森脑肿瘤症状评估量表症状干扰评估条目因子载荷矩阵

Table 2 Rotated factor loading of the symptom interference assessment items of the Chinese version of MDASI-BT

表3 两组中文版安德森脑肿瘤症状评估量表得分比较结果[分,M（P25,P75）]

Table 3 Comparison of scores on the Chinese Anderson Brain Tumor Symptom Assessment Scale between the two groups[score,M（P25,P75）]

参考文献 23

[1]	Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018,68(6):394-424. DOI URL
[2]	王宁, 刘硕, 杨雷, 等. 2018全球癌症统计报告解读[J]. 肿瘤综合治疗电子杂志, 2019,5(1):87-97.
	Wang N, Liu S, Yang L, et al. Interpretation on the report of global cancer statistics 2018[J]. J Multidiscip Cancer Manag Electron Version, 2019,5(1):87-97.
[3]	Armstrong TS, Vera-Bolanos E, Acquaye AA, et al. The symptom burden of primary brain tumors:evidence for a core set of tumor-and treatment-related symptoms[J]. Neuro Oncol, 2016,18(2):252-260. DOI URL
[4]	Alentorn A, Hoang-Xuan K, Mikkelsen T. Presenting signs and symptoms in brain tumors[J]. Handb Clin Neurol, 2016,134:19-26. DOI PMID
[5]	Huang J, Zeng C, Xiao JX, et al. Association between depression and brain tumor:a systematic review and meta-analysis[J]. Oncotarget, 2017,8(55):94932-94943. DOI PMID
[6]	吴哓哓, 李娟, 王芳, 等. 首发原发性脑肿瘤患者生命质量现状及其影响因素研究[J]. 中国慢性病预防与控制, 2018,26(11):853-857.
	Wu XX, Li J, Wang F, et al. The status of life quality of patients with first primary brain tumor and its influencing factors[J]. Chin J Prev Control Chronic Dis, 2018,26(11):853-857.
[7]	Randazzo DM, McSherry F, Herndon JE, et al. A cross sectional analysis from a single institution’s experience of psychosocial distress and health-related quality of life in the primary brain tumor population[J]. J Neurooncol, 2017,134(2):363-369. DOI URL
[8]	Coomans MB, Dirven L, Aaronson NK, et al. Symptom clusters in newly diagnosed glioma patients:which symptom clusters are independently associated with functioning and global health status?[J]. Neuro Oncol, 2019,21(11):1447-1457. DOI URL
[9]	白洁, 程敬亮, 高安康, 等. 2016年WHO中枢神经系统肿瘤分类解读[J]. 中华放射学杂志, 2016,50(12):1000-1005.
	Bai J, Cheng JL, Gao AK, et al. Interpretation of the 2016 WHO classification of tumors of central nervous system[J]. Chin J Radiol, 2016,50(12):1000-1005.
[10]	罗家洪, 郭秀花. 卫生统计学:案例版[M]. 2版. 北京: 科学出版社, 2015.
	Luo JH, Guo XH. Health statistics[M]. 2nd ed. Beijing: Science Press, 2015.
[11]	Armstrong TS, Cohen MZ, Eriksen L, et al. Content validity of self-report measurement instruments:an illustration from the development of the Brain Tumor Module of the M.D. Anderson Symptom Inventory[J]. Oncol Nurs Forum, 2005,32(3):669-676. PMID
[12]	Armstrong TS, Mendoza T, Gning I, et al. Validation of the M.D. Anderson symptom inventory brain tumor module(MDASI-BT)[J]. J Neurooncol, 2006,80(1):27-35. DOI URL
[13]	Cleeland CS, Mendoza TR, Wang XS, et al. Assessing symptom distress in cancer patients:the M.D. Anderson Symptom Inventory[J]. Cancer, 2000,89(7):1634-1646. DOI URL
[14]	Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30:a quality-of-life instrument for use in international clinical trials in oncology[J]. J Natl Cancer Inst, 1993,85(5):365-376. PMID
[15]	万崇华, 陈明清, 张灿珍, 等. 癌症患者生命质量测定量表EORTC QLQ-C30中文版评介[J]. 实用肿瘤杂志, 2005,20(4):353-355.
	Wan CH, Chen MQ, Zhang CZ, et al. The Chinese version of EORTC QLQ-C3 form in evaluation of quality of life for patients with cancer[J]. J Pract Oncol, 2005,20(4):353-355.
[16]	程金湘. 胶质瘤患者健康相关生命质量研究[D]. 西安:第四军医大学, 2013.
	Cheng JX. Health-related quality of life in glioma patients[D]. Xi’an:The Fourth Military Medical University, 2013.
[17]	Schag CC, Heinrich RL, Ganz PA. Karnofsky performance status revisited:reliability,validity,and guidelines[J]. J Clin Oncol, 1984,2(3):187-193. PMID
[18]	吴明隆. 问卷统计分析实务:SPSS操作与应用[M]. 重庆: 重庆大学出版社, 2010.
	Wu ML. Questionnaire statistical analysis practice[M]. Chong-qing: Chongqing University Press, 2010.
[19]	丁建平. 垂体腺瘤术后患者症状困扰的纵向研究[D]. 苏州:苏州大学, 2017.
	Ding JP. Longitudinal study of the symptom distress in postoperative patients with pituitary adenomas[D]. Suzhou,China:Soochow University, 2017.
[20]	赵树娟, 崔英, 张雪晴, 等. 肺栓塞患者生活质量量表的汉化和信效度检验[J]. 中华护理杂志, 2020,55(2):316-320.
	Zhao SJ, Cui Y, Zhang XQ, et al. Translation and validation of the Chinese version of PEmb-QoL questionnaire[J]. Chin J Nurs, 2020,55(2):316-320.
[21]	邱皓政. 量化研究与统计分析:SPSS中文视窗版数据分析范例解析[M]. 重庆: 重庆大学出版社, 2009.
	Qiu HZ. Quantitative research and statistical analysis[M]. Chongqing: Chongqing University Press, 2009.
[22]	沈子晨, 周漾, 朱冬梅, 等. 城市分娩创伤量表的汉化及信效度检验[J]. 中华护理杂志, 2020,55(11):1757-1761.
	Shen ZC, Zhou Y, Zhu DM, et al. Translation of the Chinese version of the City Birth Trauma Scale and the test of its reliability and validity[J]. Chin J Nurs, 2020,55(11):1757-1761.
[23]	吴婉英, 梁冠冕, 沈霞, 等. 2017年国际肿瘤护理大会学术热点分享[J]. 中国护理管理, 2017,17(12):1599-1601.
	Wu WY, Liang GM, Shen X, et al. Analysis of cancer care hotspots from the International Conference on Cancer Nursing[J]. Chin Nurs Manag, 2017,17(12):1599-1601.